About Grecian
Grecian is a Healthcare company. Pharmaceutical manufacturing and distribution of medicines and related products in India. The company has 1 employees. Its Indian entity Grecian Private Limited reported revenue of ₹19.82 Cr. Grecian offers products and services including Tablets and Injections. Its focus areas include Pharmaceuticals, Therapeutic Solutions, Specialized Treatments and Drug Manufacturing.
Company details
Grecian is recognized as a pharmaceutical company that provides a variety of products such as tablets, capsules, and injections, aimed at therapeutic areas like cardiology and oncology. Quality products are manufactured with competitive pricing and attractive packaging to serve community needs in India and internationally. A vision is held by Grecian to become a leading entity through innovative business models and adherence to values like social responsibility and sustainability. Operations are supported by certifications and a focus on research and development, ensuring products meet global standards while contributing to societal well-being and environmental nurturing.
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website grecian.in
- Legal Name Grecian Private Limited
- Date of Incorporation 25 Dec, 2020
- Jurisdiction Delhi, India
- Indian entity revenue₹19.82 Cr
FY 2025 · +5% YoY
- Indian entity net profit₹29.7 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹43.2 Lakh
FY 2025 · 2% margin
- Employee Count1
Associated legal entities of Grecian
Grecian operates through Grecian Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Grecian Private Limited CIN U24299DL2020PTC374997 | Active | 25 Dec 2020 | Delhi, Delhi | ₹19.8 Cr | 3 | View details |
Products & Services of Grecian
Grecian offers a comprehensive portfolio of products and services, including Tablets and Injections.
Tablets are manufactured by Grecian for various therapeutic uses, including treatments in cardiology and anti-diabetic categories.
Injections are produced by Grecian for critical care and oncology applications, ensuring availability in both Indian and international markets.
Board of directors of Grecian Private Limited (Grecian)
Grecian Private Limited is the primary company behind Grecian. The board of Grecian Private Limited currently have 3 directors; the longest-serving is Sunaina Bansal, appointed in 2023. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sunaina Bansal DIN 10307485 | Director | 01 Sep 2023 | 3 yrs 2 mo | Grecian Private Limited |
| Gaurav Kumar DIN 10918552 | Additional Director | 23 Jan 2025 | 1 yr 9 mo | Grecian Private Limited |
| Nehal Bansal DIN 11347912 | Additional Director | 18 Oct 2025 | 1 yr | Grecian Private Limited |
Financials of Grecian
Figures of Grecian Private Limited, the primary company behind Grecian, for FY 2025. Revenue was ₹19.82 Cr (+5% year on year). Net profit was ₹29.7 Lakh (1% margin). EBITDA was ₹43.2 Lakh (2% margin). Revenue has grown at a compounded annual rate of +77% over three years.
- ₹19.82 CrRevenue · FY 2025 · +5% YoY
- ₹29.7 LakhNet profit · 1% margin
- ₹43.2 LakhEBITDA · 2% margin
- ₹37 LakhPaid-up capital
- +77%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Grecian Private Limited are on its company page.
Detailed financial statements for Grecian
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Grecian
Grecian has 1 employees.
The primary company behind Grecian, Grecian Private Limited, reported revenue of ₹19.82 Cr for FY 2025, up 5% year on year.
Grecian is recognized as a pharmaceutical company that provides a variety of products such as tablets, capsules, and injections, aimed at therapeutic areas like cardiology and oncology. Quality products are manufactured with competitive pricing and attractive packaging to serve community needs in India and internationally. A vision is held by Grecian to become a leading entity through innovative business models and adherence to values like social responsibility and sustainability. Operations are supported by certifications and a focus on research and development, ensuring products meet global standards while contributing to societal well-being and environmental nurturing.
Grecian offers Tablets and Injections.
Grecian operates through Grecian Private Limited.
The legal entities of Grecian currently have 3 directors, including Sunaina Bansal, Gaurav Kumar, Nehal Bansal.